| |
|
|
|
Emmaus Life Sciences Inc.  
|
|
1.8 -0.07 (-0.04%) |
07-15 11:29 |
|
Open: |
1.9 |
Pre close: |
1.87 |
Target:
|
2.22
|
|
High: |
1.9 |
Low: |
1.8 |
Resistance:
|
1.90
2.22
|
|
Volume: |
48,895 |
Market Cap: |
87M |
Support:
|
1.65
 1.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.69
|
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
1.72 |
Signal(12,26,9): |
0.04  |
|
MA(100): |
1.54 |
Stochastic Oscillator |
%K(14,3):
|
55.83 |
|
MA(250): |
2.24 |
%D(3): |
40.00 |
|
Average Volume(K) |
3-Month: |
2251
|
52-Week |
High:
|
9.20 |
|
10-Days: |
2781 |
Low: |
0.85 |
|
RSI |
RSI(14):
|
55.84 |
Change(%): |
-71.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.089 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
48.47 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-3.2 |
Shares Float (M) |
29.24 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
21.59 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
24.6 |
% Held by Institutions |
0.48 |
|
Forward EPS |
-1.650 |
Gross Profit (p.s.) |
0.295 |
Shares Short (K) |
41 |
|
Book Value (p.s.) |
-0.370 |
EBITDA (p.s.) |
-0.074 |
P/E |
-0.86 |
|
Sales Per Share |
0.497 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.86 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.99 |
P/S |
3.62 |
|
Operating Margin |
-15.20 |
Levered Free Cash Flow
(M) |
9.96 |
P/CF |
-14.57 |
|
|
|
|
|
|
